Aminoglutethimide Articles
New "targeted" approach to delivering drugs for breast cancer
11 October 2004
Ciba Launches Femara And Diovan In The UK
2 December 1996
Zeneca's Arimidex Launched In First Market
25 September 1995
Euro Epidemiology TrendsTo Year 2010; Cancer
17 October 1994
NEW PRODUCTS APPROVED IN UK
4 January 1993
ZENECA'S PROMISING R&D PIPELINE PRESENTED
14 December 1992
Showing 1-6 of 6 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
